![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/pantherxrare-selected-by-edenbridge-pharmaceuticals-as-specialty-pharmacy-for-yargesa-miglustat-100-mg-capsules-302104863.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2023-82126.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213796
https://www.biospace.com/article/releases/edenbridge-pharmaceuticals-announces-u-s-fda-approval-of-dartisla-odt-glycopyrrolate-orally-disintegrating-tablets/
https://www.catalent.com/catalent-news/catalent-to-supply-edenbridge-pharmaceuticals-with-a-fast-dissolve-zydis-formulation-of-glycopyrrolate-intended-as-adjunctive-therapy-for-patients-with-peptic-ulcer/